Active Ingredient: Palbociclib
Palib 100mg contains Palbociclib, a targeted therapy used to treat advanced or metastatic breast cancer. It works by inhibiting certain enzymes known as CDK4 and CDK6, which are responsible for regulating cell division. By blocking these enzymes, Palib 100mg helps to slow or stop the growth of cancer cells, particularly in hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancers.
Indications:
- Advanced or metastatic breast cancer (HR+/HER2-)
Mechanism of Action:
Palib 100mg works by inhibiting the activity of cyclin-dependent kinases (CDK4 and CDK6), which are crucial in cell division. This action slows the progression of cancer by preventing cancer cells from multiplying.
Dosage Form: 100mg Tablets
Prescription Requirement:
Palib 100mg is available by prescription and should be used under the supervision of a healthcare provider who will monitor its effects and adjust the dosage as necessary.
Advantages of Palib 100mg:
-
Targeted Therapy:
-
Improves Progression-Free Survival:
-
Effective in Combination Therapy:
-
Oral Administration:
-
Delays Need for Chemotherapy: